On July 25, shares of GC Green Cross Wellbeing (234690.KQ) rocketed 19.16% to close at 14,680 won, fueled by the announcement of its new human tissue-based extracellular matrix (ECM) skin booster, Giselle Rebonne. This leap underscores surging investor enthusiasm for advanced regenerative aesthetics in South Korea's booming beauty market.
Giselle Rebonne: A Leap in Skin Regeneration
Giselle Rebonne represents a next-generation ECM skin booster derived from human acellular dermal matrix (hADM). Unlike traditional boosters that merely stimulate collagen indirectly, this product delivers the ECM structure directly, fostering tissue remodeling and structural restoration for deeper skin rejuvenation.
- Processed by MS Bio using proprietary decellularization to eliminate cells and immune triggers, ensuring high biocompatibility.
- GC Green Cross Wellbeing supplies raw materials via its Eumseong tissue bank, minimizing rejection risks and inflammation.
- Offers fundamental regenerative effects, positioning it as a superior option for anti-aging and skin repair.
Strategic Portfolio Expansion
The launch bolsters GC Green Cross Wellbeing's aesthetic lineup, now spanning placenta injections like Laennec, dermal fillers, skin boosters, and botulinum toxin Innovo. This diversification mirrors industry shifts toward comprehensive regenerative solutions, capitalizing on demand for minimally invasive, long-lasting beauty treatments.
Competitive Landscape and Market Trends
South Korea's aesthetics sector is heating up, with peers like Hugel pursuing co-promotions with Hans Biomed's Cellrderm ECM booster, and CG Bio planning bundled sales with Daewoong's Nabota and V-Olet. The ECM category taps into global trends where consumers seek bio-compatible, human-derived therapies amid rising interest in preventive skin health and personalized medicine.
Investor confidence reflects broader implications: as regenerative tech advances, companies blending biotech with cosmetics could dominate, potentially reshaping standards for safe, effective beauty innovations while addressing aging populations' needs worldwide.
